Pfenex Inc Stock News

Pfenex Inc. (NYSE American: PFNX) is a development and licensing biotechnology company focused on leveraging its proprietary protein production platform, Pfenex Expression Technology®, to develop nex

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks hitting 52-week highs May 6.) Adverum Biotechnologies Inc...

Two new coronavirus drugs, Interferon Beta and Avigan, might just be able to cure COVID-19

Biotech stocks started last week on a strong note but the upward momentum slowed through the week. The week saw a slew of earnings from big pharma names, including Merck...

NEW YORK (AP) —The following list shows the NYSE MKT-listed stocks that have gone up the most and down the most based on percent of change for 2019. No securities trading below 1000 shar

SAN DIEGO, April 24, 2020 -- Pfenex Inc. (NYSE American: PFNX) announced today that it will report its financial results for the first quarter ended March 31, 2020, after the.

There's a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Pfenex (PFNX) and Autolus Therapeutics (AUTL) with bullish

Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Pfenex Inc. ("Pfenex" or "the Company") (NASDAQ: PFNX). Investors who purchased

The latest analyst coverage could presage a bad day for Pfenex Inc. (NYSEMKT:PFNX), with the analysts making...

Toward the end of trading Wednesday, the Dow traded down 1.5% to 23589.88 while the NASDAQ fell 0.98% to 8,432.13. The S&P also fell, dropping 1.78% to 2,795.28. The U.S. is...